Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Paolo Fiorino  LinkedIn

Executive Vice President,
North America API and Formulations, Piramal Pharma Solutions

Paolo Fiorino is the Executive Vice President at Piramal Pharma Solutions (PPS). He leads the API and Formulations Operations in North America, along with overseeing the Aurora, Riverview and Sellersville Sites. He is responsible for formulating and consolidating the North American strategy and accelerating PPS regional growth plans in line with its business roadmap. Mr. Fiorino is also involved in driving synergies across the North American operations; with focus on supporting the business through robust operational excellence, patient-centricity, quality and EHS focus and strong customer centric manufacturing processes.

Mr. Fiorino has over two decades of diverse experience in pharmaceutical drug product & Active Pharmaceutical Ingredient (API) manufacturing having held leadership roles in general management, plant operations and engineering.

Prior to joining Piramal, Mr. Fiorino was the MD and General Manager with Teva, leading their sites in Italy and Mexico. He was also responsible for Teva's Canadian operations in the multi-dose formulations space across three sites. He also worked at Apotex, Canada, where he held various leadership roles. His early work experience spans across food & beverage, consumer packaged goods and automotive sectors.

Mr. Fiorino holds a Bachelor's degree in Chemical Engineering from the University of Toronto.

Leadership Team

Peter DeYoung    LinkedIn

CEO, Piramal Global Pharma

Stuart Needleman    LinkedIn

Chief Commercial Officer &
Chief Patient Centricity Officer, Piramal Pharma Solutions

Herve Berdou    LinkedIn

Chief Operating Officer, Piramal Pharma Solutions

Robert Munday    LinkedIn

Executive Vice President,
Aeseptic and Biologics, Piramal Pharma Solutions

Debashish Chakravorty    LinkedIn

Executive Vice President, India and UK Formulations

Surinder Gulati    LinkedIn

Executive Vice President,
India API and Operations, Piramal Pharma Solutions

Rashida Najmi    LinkedIn

Chief Quality Officer, Piramal Pharma Solutions

Christopher Leahy    LinkedIn

Senior Vice President,
Finance, Piramal Pharma Solutions